CDK9 inhibitors: A promising new treatment for hematological malignancies

A new research perspective was published in Oncotarget’s Volume 14 on August 7, 2023, entitled, “CDK9 INHIBITORS: a promising combination partner in the treatment of hematological malignancies.”

Tech companies pitch AI platforms for healthcare, outline plans for responsible rollout

Listen to the article 8 min This audio is auto-generated. Please let us know if you have feedback. LAS VEGAS — Executives from America’s largest

November 1, 2024

New device promises reliable rehabilitation for balance disorders

The University of the Basque Country (UPV/EHU) has presented a promising device designed to conduct measurements reliably and repeatably when treating the after-effects of stroke,

January 22, 2025

RFK Jr. is crowdsourcing reams of nominees for Trump’s health administration

Between now and Inauguration Day, President-elect Donald Trump and his allies will have the Herculean task of appointing 4,000 people to staff his administration. Trump

November 8, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.